Literature DB >> 19944604

Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.

Eder Zucconi1, Marcos Costa Valadares, Natássia M Vieira, Carlos R Bueno, Mariane Secco, Tatiana Jazedje, Helga Cristina Almeida da Silva, Mariz Vainzof, Mayana Zatz.   

Abstract

Of the various genetic homologues to Duchenne Muscular Dystrophy (DMD), the Golden Retriever Muscular Dystrophy (GRMD) dog, which presents a variable but usually severe and progressive muscle weakness, has the closest relevance to DMD in both clinical severity and histopathological change. Among 77 GRMD dogs born in our colony in Brazil, we have identified a very mildly affected dog, Ringo, born July 2003. Among his descendants, at least one male, Suflair, is also showing a mild course. In an attempt to better characterize these two dogs, we studied the pattern of muscle proteins expression in Ringo and Suflair, as compared to severely affected and normal control dogs. Dystrophin was absent in both and utrophin was overexpressed in a pattern similar to the observed in severely affected dogs. Understanding the mechanism that is protecting Ringo and Suflair from the deleterious effect of the dystrophin gene mutation is of utmost interest. In addition it points out that the clinical impact of therapeutic trials should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19944604     DOI: 10.1016/j.nmd.2009.10.011

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  18 in total

1.  Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.

Authors:  Natassia M Vieira; Janelle M Spinazzola; Matthew S Alexander; Yuri B Moreira; Genri Kawahara; Devin E Gibbs; Lillian C Mead; Sergio Verjovski-Almeida; Mayana Zatz; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

2.  Duchenne muscular dystrophy gene therapy: Lost in translation?

Authors:  Dongsheng Duan
Journal:  Res Rep Biol       Date:  2011-03

Review 3.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

4.  Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Authors:  M V Pelatti; J P A Gomes; N M S Vieira; E Cangussu; V Landini; T Andrade; M Sartori; L Petrus; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

Review 5.  Modifying muscular dystrophy through transforming growth factor-β.

Authors:  Ermelinda Ceco; Elizabeth M McNally
Journal:  FEBS J       Date:  2013-04-24       Impact factor: 5.542

6.  Dystrophin insufficiency causes selective muscle histopathology and loss of dystrophin-glycoprotein complex assembly in pig skeletal muscle.

Authors:  Katrin Hollinger; Cai X Yang; Robyn E Montz; Dan Nonneman; Jason W Ross; Joshua T Selsby
Journal:  FASEB J       Date:  2013-12-17       Impact factor: 5.191

7.  Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.

Authors:  Natassia M Vieira; Ingegerd Elvers; Matthew S Alexander; Yuri B Moreira; Alal Eran; Juliana P Gomes; Jamie L Marshall; Elinor K Karlsson; Sergio Verjovski-Almeida; Kerstin Lindblad-Toh; Louis M Kunkel; Mayana Zatz
Journal:  Cell       Date:  2015-11-12       Impact factor: 41.582

8.  Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice.

Authors:  Mariane Secco; Carlos Bueno; Natassia M Vieira; Camila Almeida; Mayra Pelatti; Eder Zucconi; Paolo Bartolini; Mariz Vainzof; Elen H Miyabara; Oswaldo K Okamoto; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2013-02       Impact factor: 5.739

Review 9.  Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy.

Authors:  Alicja Starosta; Patryk Konieczny
Journal:  Cell Mol Life Sci       Date:  2021-04-07       Impact factor: 9.261

10.  Comparative Genomics of X-linked Muscular Dystrophies: The Golden Retriever Model.

Authors:  Candice Brinkmeyer-Langford; Joe N Kornegay
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.